• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保健文献中的成本效益分析:勿以标签评判研究。

Cost-benefit analyses in the health-care literature: don't judge a study by its label.

作者信息

Zarnke K B, Levine M A, O'Brien B J

机构信息

Department of Medicine, London Health Sciences Centre, University of Western Ontario, Ontario, Canada.

出版信息

J Clin Epidemiol. 1997 Jul;50(7):813-22. doi: 10.1016/s0895-4356(97)00064-4.

DOI:10.1016/s0895-4356(97)00064-4
PMID:9253393
Abstract

OBJECTIVES

To assess whether health-care related economic evaluations labeled as "cost benefit analyses" (CBA) meet a contemporary definition of CBA methodology and to assess the prevalence of methods used for assigning monetary units to health outcomes.

DATA SOURCES

Medline, Current Contents, and HSTAR databases and reference lists of review articles, 1991-1995.

STUDY SELECTION

Economic analyses labeled as CBAs were included. Agreement on study selection was assessed. STUDY EVALUATION: CBA studies were classified according to standard definitions of economic analytical techniques. For those valuing health outcomes in monetary units (bona fide CBAs), the method of valuation was classified.

RESULTS

53% of 95 studies were reclassified as cost comparisons because health outcomes were not appraised. Among the 32% considered bona fide CBAs, the human capital approach was employed to value health states in monetary units in 70%. Contingent valuation methods were employed infrequently (13%).

CONCLUSIONS

Studies labeled as CBAs in the health-care literature often offer only partial program evaluation. Decisions based only on resource costs are unlikely to improve efficiency in resource allocation. Among bona fide CBAs, the human capital approach was most commonly used to valuing health, despite its limitations. The results of health-care related CBAs should be interpreted with extreme caution.

摘要

目的

评估标记为“成本效益分析”(CBA)的医疗保健相关经济评估是否符合CBA方法的当代定义,并评估用于为健康结果赋予货币单位的方法的流行程度。

数据来源

1991年至1995年的Medline、《现刊目次》和HSTAR数据库以及综述文章的参考文献列表。

研究选择

纳入标记为CBA的经济分析。评估了研究选择的一致性。

研究评估

根据经济分析技术的标准定义对CBA研究进行分类。对于那些用货币单位评估健康结果的研究(真正的CBA),对评估方法进行了分类。

结果

95项研究中有53%被重新归类为成本比较,因为未对健康结果进行评估。在被视为真正CBA的32%的研究中,70%采用人力资本方法用货币单位评估健康状态。很少使用意愿评估法(13%)。

结论

医疗保健文献中标记为CBA的研究通常仅提供部分项目评估。仅基于资源成本的决策不太可能提高资源配置效率。在真正的CBA中,尽管存在局限性,但人力资本方法最常用于评估健康。与医疗保健相关的CBA结果应极其谨慎地解读。

相似文献

1
Cost-benefit analyses in the health-care literature: don't judge a study by its label.医疗保健文献中的成本效益分析:勿以标签评判研究。
J Clin Epidemiol. 1997 Jul;50(7):813-22. doi: 10.1016/s0895-4356(97)00064-4.
2
Economic analysis in dermatology.皮肤病学中的经济分析。
J Am Acad Dermatol. 2002 Feb;46(2):271-83. doi: 10.1067/mjd.2002.119566.
3
The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.经济评估中的分配问题:收入与医疗保健项目成本及后果的估值
Health Econ. 2002 Jan;11(1):55-70. doi: 10.1002/hec.642.
4
The impact of economic evaluation on quality management in spine surgery.经济评估对脊柱外科质量管理的影响。
Eur Spine J. 2009 Aug;18 Suppl 3(Suppl 3):338-47. doi: 10.1007/s00586-009-0939-3. Epub 2009 Apr 1.
5
Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.医疗保健项目经济评估背景下的支付意愿:理论与实践
Am J Manag Care. 1997 May;3 Suppl:S21-32.
6
Cost-utility and cost-benefit analyses: how did we get here and where are we going?成本效用分析和成本效益分析:我们是如何走到这一步的,又将走向何方?
Eur J Gastroenterol Hepatol. 2004 Jun;16(6):527-34. doi: 10.1097/00042737-200406000-00004.
7
Quality of life and health economics: where is the link?生活质量与健康经济学:联系何在?
Scand J Gastroenterol Suppl. 1996;221:33-6. doi: 10.3109/00365529609095553.
8
Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?成本效益/效用分析。当前的决策规则能引领我们实现目标吗?
J Health Econ. 1992 Oct;11(3):279-96. doi: 10.1016/0167-6296(92)90004-k.
9
Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.存在外部性时基于成本效用分析进行医疗保健资源分配的影响。
J Health Econ. 1992 Oct;11(3):259-77. doi: 10.1016/0167-6296(92)90003-j.
10
Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science.医疗保健领域成本效益分析方法的最新进展。使艺术与科学相匹配。
Pharmacoeconomics. 1999 Apr;15(4):357-67. doi: 10.2165/00019053-199915040-00003.

引用本文的文献

1
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations.用于为医疗保健中的优先事项设定和资源分配提供信息的主要类型经济评估简介:主要特点、用途和局限性。
Front Public Health. 2021 Aug 25;9:722927. doi: 10.3389/fpubh.2021.722927. eCollection 2021.
2
Adult Perceptions of Different Orthodontic Appliances.成人对不同正畸矫治器的认知。
Patient Prefer Adherence. 2019 Dec 13;13:2119-2128. doi: 10.2147/PPA.S234449. eCollection 2019.
3
Economics of public health programs for underserved populations: a review of economic analysis of the National Breast and Cervical Cancer Early Detection Program.
服务不足人群的公共卫生计划经济学:国家乳腺癌和宫颈癌早期检测计划经济分析综述。
Cancer Causes Control. 2019 Dec;30(12):1351-1363. doi: 10.1007/s10552-019-01235-6. Epub 2019 Oct 9.
4
A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications in Egypt.埃及药物经济学文献的范围和质量的系统评价。
Clin Drug Investig. 2019 Feb;39(2):157-168. doi: 10.1007/s40261-018-0730-5.
5
Cost-effectiveness of human papillomavirus vaccination in Germany.人乳头瘤病毒疫苗在德国的成本效益
Cost Eff Resour Alloc. 2017 Sep 4;15:18. doi: 10.1186/s12962-017-0080-9. eCollection 2017.
6
Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?福利主义与超福利主义:经济评价方法的选择会影响经济评价研究推荐的采用决策吗?
Pharmacoeconomics. 2015 Jun;33(6):571-9. doi: 10.1007/s40273-015-0261-3.
7
Do economic evaluation studies inform effective healthcare resource allocation in Iran? A critical review of the literature.经济评估研究是否为伊朗有效的医疗资源分配提供了信息?文献综述。
Cost Eff Resour Alloc. 2014 Jul 11;12:15. doi: 10.1186/1478-7547-12-15. eCollection 2014.
8
The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review.津巴布韦的健康经济与药物经济学评价研究现状:综述
Curr Ther Res Clin Exp. 2008 Jun;69(3):268-85. doi: 10.1016/j.curtheres.2008.06.005.
9
Evaluating the economics of complementary and integrative medicine.评估补充与整合医学的经济学情况。
Glob Adv Health Med. 2013 Mar;2(2):56-63. doi: 10.7453/gahmj.2013.002.
10
Economic evaluations in shoulder pathologies: a systematic review of the literature.肩关节炎的经济学评价:文献系统回顾。
J Shoulder Elbow Surg. 2012 Mar;21(3):367-75. doi: 10.1016/j.jse.2011.05.019. Epub 2011 Aug 23.